Source: FinanzNachrichten

Casma: Casma Therapeutics, Inc.: Casma Therapeutics and Vipergen Enter Into Drug Discovery Agreement

Casma Therapeutics, Inc. and Vipergen ApS announced today the signing of a drug discovery agreement. Under the terms of the agreement, Vipergen will apply its proprietary high-fidelity DNA-encoded...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Frank Gentile's photo - President & CEO of Casma

President & CEO

Frank Gentile

CEO Approval Rating

83/100

Read more